Erratum: Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in medicine : official journal of the American College of Medical Genetics (2019) 21 1 (44-52))

Published on Aug 1, 2019in Genetics in Medicine8.822
· DOI :10.1038/S41436-018-0258-3
Hiroki Maruyama26
Estimated H-index: 26
(Niigata University),
Kaori Miyata3
Estimated H-index: 3
+ 28 AuthorsSatoshi Ishii38
Estimated H-index: 38
Cited By2
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.